By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Depomed, Inc. 

1360 O'Brien Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-462-5900 Fax: 650-462-9993



Drug Delivery

Company News
Depomed, Inc. (DEPO) Announces Pricing Of Upsized $300 Million Convertible Senior Notes Due 2021 9/5/2014 1:01:31 PM
Depomed, Inc. (DEPO) Summary Judgment Motion Granted In Suit Against FDA Seeking Orphan Drug Exclusivity For GraliseĀ® (Gabapentin) 9/5/2014 12:56:26 PM
Depomed, Inc. (DEPO) Announces Offering Of $230 Million Convertible Senior Notes Due 2021 9/3/2014 4:15:51 PM
Depomed, Inc. (DEPO) To Present At Morgan Stanley 2014 Global Healthcare Conference 8/26/2014 8:58:29 AM
Depomed, Inc. (DEPO) Prevails in GraliseĀ® ANDA Litigation Blocking Generic Entry Until 2024 8/19/2014 10:39:25 AM
Depomed, Inc. (DEPO) Reports Second Quarter 2014 Financial Results 8/7/2014 8:46:46 AM
Depomed, Inc. (DEPO) Announces Appointment of R. Scott Shively As Chief Commercial Officer 8/5/2014 7:06:44 AM
Depomed, Inc. (DEPO) To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 7/28/2014 8:31:27 AM
Depomed, Inc. (DEPO) Announces District Court Order In ANDA Litigation 7/18/2014 9:16:50 AM
Depomed, Inc. (DEPO) Announces Appointment Of Srinivas G. Rao, MD, PhD, As Chief Medical Officer 7/16/2014 11:04:34 AM